Clinical Trials Browser

Phase 2 × Completed × Recurrent High Grade Meningioma × Clear all

NCT02234050 2025-07-10

Trabectedin for Recurrent Grade II/III Meningioma

Phase 2 Completed

90 enrolled 18 charts

Recurrent High Grade Meningioma